Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.
Herpes simplex virus (HSV) recombinants are being developed as vaccine vectors for the expression of heterologous antigens. There is concern, however, that preexisting HSV immunity may decrease their effectiveness. We have addressed this issue in an animal model. Immunized mice were inoculated with a replication-defective HSV-1 vector that expressed the Escherichia coli beta-galactosidase protein as a model antigen. We assessed vector efficacy by analyzing the immunoglobulin G (IgG) antibody response and cellular proliferative response directed against beta-galactosidase. We report that the ability of the vector to induce antibody or proliferative responses was not diminished by preexisting immunity to HSV. Of further note, the anti-HSV and anti-beta-galactosidase IgG responses following vector administration were extremely durable in both immunized and naive mice. These results indicate that the ability of a replication-defective HSV-derived vaccine vector to elicit long-lived immune responses in mice is not impaired by prior HSV exposure.
Brockman
Mark A
MA
Department of Microbiology and Molecular Genetics and Committee on Virology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Knipe
David M
DM
D000818:Animals; D003673:Defective Viruses; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000201:enzymology / Q000235:genetics; D005260:Female; D005822:Genetic Vectors; D006561:Herpes Simplex / Q000235:genetics / Q000276:immunology*; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000276:immunology; D022283:Herpesvirus Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D014779:Virus Replication; D001616:beta-Galactosidase / Q000235:genetics / Q000276:immunology / Q000378:metabolism
D022283:Herpesvirus Vaccines; D007074:Immunoglobulin G; D001616:beta-Galactosidase